MedTrace Logo

PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)

NCT04142359 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2024-12-10

Study results available
· View outcomes & findings →

Summary

Non-interventional PK sub-study of QUILT-3.032 (CA-ALT-803-01-16) and QUILT-2.005 (CA-ALT-803-01-14)

Conditions

  • Pharmacokinetics

Interventions

BIOLOGICAL

BCG in Combination with N-803

BCG in Combination with N-803

DRUG

N-803 alone

N-803 alone

Sponsors & Collaborators

  • Altor BioScience

    lead INDUSTRY

Principal Investigators

  • Chad Garner, PhD · ImmunityBio, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-09
Primary Completion
2020-04-06
Completion
2020-04-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04142359 on ClinicalTrials.gov